# Hans Biomed Corporation – FDA Inspection, Mar 31, 2016

Source: https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/e1f3a509-f207-4dcb-ab3e-2273cae164b8
Source feed: FDA_Inspections

> FDA inspection 966652 of Hans Biomed Corporation, March 31, 2016. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 966652
- Company Name: Hans Biomed Corporation
- Inspection Date: 2016-03-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1282278 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/787c4d50-6cdc-4aae-bfa1-ad7d16f5af80)
- [FDA Inspection 1216052 - 2023-08-25](https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/c9aabe20-af7a-4aed-ab22-36696d9695f0)
- FDA Inspection 1091073 - 2019-04-05
- FDA Inspection 893493 - 2014-06-03
- FDA Inspection 848720 - 2013-08-29

Company: https://www.keypedia.com/companies/hans-biomed-corporation/60abe6f2-149e-4591-8422-7edc574c65a7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
